Alterity Therapeutics Limited (PBN) - Total Liabilities

Latest as of December 2025: €2.65 Million EUR ≈ $3.10 Million USD

Based on the latest financial reports, Alterity Therapeutics Limited (PBN) has total liabilities worth €2.65 Million EUR (≈ $3.10 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Alterity Therapeutics Limited strategic investment ratio to see how much of total assets are deployed in long-term investments.

Alterity Therapeutics Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Alterity Therapeutics Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PBN current and non-current assets.

Alterity Therapeutics Limited Competitors by Total Liabilities

The table below lists competitors of Alterity Therapeutics Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Malee Group Public Company Limited BK:MALEE	Thailand	฿2.83 Billion
Gedeon Richter PLC LSE:0QFP	UK	£249.71 Billion
Nordisk Bergteknik AB Series B ST:NORB-B	Sweden	Skr2.15 Billion
Done.ai Group AB ST:DONE	Sweden	Skr292.26 Million
Futebol Clube do Porto - Futebol S.A.D. LS:FCP	Portugal	€517.23 Million
SensorView Co Ltd KQ:321370	Korea	₩23.52 Billion
Cauldron Energy Ltd AU:CXU	Australia	AU$1.01 Million
Yatra Online Inc NASDAQ:YTRA	USA	$5.56 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Alterity Therapeutics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Alterity Therapeutics Limited balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	21.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alterity Therapeutics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alterity Therapeutics Limited (2014–2025)

The table below shows the annual total liabilities of Alterity Therapeutics Limited from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	€3.62 Million ≈ $4.24 Million	-33.22%
2024-06-30	€5.43 Million ≈ $6.34 Million	+20.44%
2023-06-30	€4.50 Million ≈ $5.27 Million	-23.57%
2022-06-30	€5.89 Million ≈ $6.89 Million	+89.20%
2021-06-30	€3.12 Million ≈ $3.64 Million	+13.00%
2020-06-30	€2.76 Million ≈ $3.22 Million	-17.83%
2019-06-30	€3.36 Million ≈ $3.92 Million	+26.86%
2018-06-30	€2.64 Million ≈ $3.09 Million	+66.25%
2017-06-30	€1.59 Million ≈ $1.86 Million	-32.53%
2016-06-30	€2.36 Million ≈ $2.76 Million	-13.35%
2015-06-30	€2.72 Million ≈ $3.18 Million	-31.19%
2014-06-30	€3.95 Million ≈ $4.62 Million	--

About Alterity Therapeutics Limited

F:PBN Germany Biotechnology

Market Cap

$3.43 Billion

€2.94 Billion EUR

Market Cap Rank

#20951 Global

#1879 in Germany

Share Price

€0.27

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.41

All Time High

€0.41